Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Selective angiotensin AT2 receptor agonists described by Vicore Pharma

July 13, 2004

European approval for Pariet for Zollinger-Ellison syndrome

July 12, 2004

Antiviral nucleoside derivatives for the treatment of hepatitis C

July 9, 2004

FDA approves new dosing options for Prevacid SoluTab

July 9, 2004

Gastric and intestinal protectants claimed in Altana patent

July 8, 2004

Patent claims new method to treat GI disorders with duloxetine

July 7, 2004

Solvay researchers describe series of 5-HT3 receptor antagonists

July 7, 2004

Achillion Pharmaceuticals claims inhibitors of hepatitis C virus replication

July 6, 2004

Enrollment under way in two phase III Leukine studies for Crohn's disease

July 6, 2004

Prevacid approved for use in adolescents

July 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026